Matches in Wikidata for { <http://www.wikidata.org/entity/Q64714647> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q64714647 description "clinical trial" @default.
- Q64714647 description "ensayu clínicu" @default.
- Q64714647 description "klinisch onderzoek" @default.
- Q64714647 description "клінічне випробування" @default.
- Q64714647 name "Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)" @default.
- Q64714647 type Item @default.
- Q64714647 label "Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)" @default.
- Q64714647 prefLabel "Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)" @default.
- Q64714647 P1050 Q64714647-831B835D-8BA6-4D22-A24D-D87EB9472D48 @default.
- Q64714647 P1132 Q64714647-2FBB8251-C74D-42AF-BCAD-6C3D4AAAF007 @default.
- Q64714647 P1476 Q64714647-AFD9D125-D4C3-406A-B046-788AC91C708C @default.
- Q64714647 P17 Q64714647-1472C767-D810-4F12-B7FA-A2843BBB19AF @default.
- Q64714647 P17 Q64714647-159BA749-D608-410A-A24D-F84DEDE5A58D @default.
- Q64714647 P17 Q64714647-35719364-3536-4BAB-A0B1-5B6E7E35844C @default.
- Q64714647 P17 Q64714647-37DBAB67-4493-4170-BA65-311B9DB5CF86 @default.
- Q64714647 P17 Q64714647-9E662CA0-719F-4397-AA6C-89ABD50CD1E7 @default.
- Q64714647 P17 Q64714647-9FC7CAB2-F4C5-4A57-BC24-0E3348BE68D7 @default.
- Q64714647 P17 Q64714647-ADF34E5D-E890-4058-A0D4-6CB4F5FCCFAF @default.
- Q64714647 P17 Q64714647-B82D5D63-0DDF-4C6A-BD69-D8430AF919B4 @default.
- Q64714647 P17 Q64714647-CCBFBB87-81AD-4F50-A2E8-7E38192E5C66 @default.
- Q64714647 P17 Q64714647-DE702AC8-4252-43A7-9093-B3A1D0270720 @default.
- Q64714647 P17 Q64714647-E3C9CA83-66B7-48E8-8EC5-7B9629BEAB5A @default.
- Q64714647 P17 Q64714647-E9F39237-CBB1-4D0F-8D97-A24AD66E5676 @default.
- Q64714647 P17 Q64714647-F5EAE3FD-6593-490E-9AF2-31A2090092DC @default.
- Q64714647 P17 Q64714647-FA1A9A9D-AC32-479D-8CF8-4C004FFC4C07 @default.
- Q64714647 P2899 Q64714647-5524066F-C904-448B-8AF9-4C54B79A4F77 @default.
- Q64714647 P3098 Q64714647-8D04DFCA-0019-439F-8BED-B83868C7E35A @default.
- Q64714647 P31 Q64714647-5B1B312A-EDF8-4835-8E61-4AD576178CD9 @default.
- Q64714647 P4135 Q64714647-5A61C735-EDBA-462C-A867-FB80E34D29DD @default.
- Q64714647 P580 Q64714647-F43C98A9-81D6-4CF2-87E8-32182817EADD @default.
- Q64714647 P582 Q64714647-94F8BD88-9DE3-432C-9A51-C715E106F6FE @default.
- Q64714647 P6099 Q64714647-BC346A41-1AAA-4FE6-A2DA-0EC02B9D36A3 @default.
- Q64714647 P8363 Q64714647-99442A78-3EDE-4F22-91EC-B87C417A9B2C @default.
- Q64714647 P1050 Q35869 @default.
- Q64714647 P1132 "+453" @default.
- Q64714647 P1476 "A Phase III Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (5 mcg/Day) Over 48 Weeks as add-on Controller Therapy on Top of Usual Care in Patients With Severe Persistent Asthma" @default.
- Q64714647 P17 Q145 @default.
- Q64714647 P17 Q16 @default.
- Q64714647 P17 Q17 @default.
- Q64714647 P17 Q183 @default.
- Q64714647 P17 Q212 @default.
- Q64714647 P17 Q258 @default.
- Q64714647 P17 Q30 @default.
- Q64714647 P17 Q35 @default.
- Q64714647 P17 Q38 @default.
- Q64714647 P17 Q403 @default.
- Q64714647 P17 Q408 @default.
- Q64714647 P17 Q43 @default.
- Q64714647 P17 Q55 @default.
- Q64714647 P17 Q664 @default.
- Q64714647 P2899 "+18" @default.
- Q64714647 P3098 "NCT00776984" @default.
- Q64714647 P31 Q30612 @default.
- Q64714647 P4135 "+75" @default.
- Q64714647 P580 "2008-10-01T00:00:00Z" @default.
- Q64714647 P582 "2011-07-01T00:00:00Z" @default.
- Q64714647 P6099 Q42824827 @default.
- Q64714647 P8363 Q78089383 @default.